Table 3.

Multivariable associations of consumption of concentrated sugars (grams) from sugar-sweetened beverages with prostate cancer risk^*,^†

	No PSA Screens			≥ 1 PSA Screen
	N Cases/Total Person-Years	HR	95% CI	N Cases/Total Person-Years	HR	95% CI	P‡
Q1	180/20059	1.00	–	216/24553	1.00	–
Q2	225/20123	1.16	0.95, 1.41	253/23447	1.04	0.86, 1.24	0.40
Q3	219/20209	1.15	0.94, 1.40	271/21526	1.15	0.97, 1.38	0.95
Q4	218/20511	1.18	0.97, 1.44	271/17630	1.17	0.97, 1.4	0.92
	White			Non-White
	N Cases/Total Person-Years	HR	95% CI	N Cases/Total Person-Years	HR	95% CI	P‡
Q1	368/39120	1.00	––	38/2835	1.00	––
Q2	448/40082	1.22	0.98, 1.29	46/3365	1.07	0.70, 1.63	0.83
Q3	488/41140	1.20	1.04, 1.37	34/4566	0.78	0.49, 1.22	0.07
Q4	513/46084	1.19	1.03, 1.36	61/6238	1.21	0.80, 1.82	0.94

^*Adjusted for age, race, study center, BMI, education, smoking, family history of prostate cancer, history of diabetes, PSA screening, and energy intake

^†Quartile cutpoints (g/d): No PSA screens - 0.89, 5.95, 21.17; ≥ 1 PSA screen - 0.63, 4.13, 17.23; White - 0.63, 3.92, 16.42; Non-white 21.19, 7.74, 22.67

^‡P value from heterogeneity test